3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Apo AI Nanoparticles Delivered Post Myocardial Infarction Moderate Inflammation.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Decades of research have examined immune-modulatory strategies to protect the heart after an acute myocardial infarction and prevent progression to heart failure but have failed to translate to clinical benefit.

          Related collections

          Author and article information

          Journal
          Circ Res
          Circulation research
          Ovid Technologies (Wolters Kluwer Health)
          1524-4571
          0009-7330
          November 06 2020
          : 127
          : 11
          Affiliations
          [1 ] Baker Heart and Diabetes Institute, Melbourne, Australia (A.L.R., M.R., M.K., A.L.N., S.E.H., G.L.L., A.J.M., B.G.D., B.A.K.).
          [2 ] CSL Behring, Bern, Switzerland (S.A.D., A.V.N.).
          [3 ] Department of Physiology (B.A.K.), Monash University, Melbourne, Australia.
          [4 ] School of Medicine (B.A.K.), Monash University, Melbourne, Australia.
          [5 ] CSL Ltd, Bio21, Parkville, Australia (B.A.K.).
          Article
          10.1161/CIRCRESAHA.120.316848
          32951519
          f1f85c80-da2f-49aa-aa7a-1973d292fed0
          History

          apolipoprotein,inflammation,monocyte,myocardial infarction,percutaneous coronary interventions

          Comments

          Comment on this article